| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $17.3M | +14.9% |
| SG&A Expense | $14.0M | +11.4% |
| Operating Income | -$31.4M | -13.3% |
| Pre-tax Income | -$30.1M | -11.6% |
| Income Tax | $0 | — |
| Net Income | -$30.1M | -11.6% |
| EPS (Basic) | -$0.24 | -14.3% |
| EPS (Diluted) | -$0.24 | -14.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.5M | -20.2% |
| Current Assets | $92.2M | -22.0% |
| Total Assets | $96.3M | -22.1% |
| Current Liabilities | $5.2M | -6.0% |
| Total Liabilities | $5.2M | -6.0% |
| Stockholders' Equity | $91.0M | -22.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.9M | -0.9% |
| Capital Expenditures | $14K | -48.1% |
| Investing Cash Flow | -$14K | +99.7% |
| Financing Cash Flow | -$1.5M | — |
| Free Cash Flow | -$21.0M | -0.8% |